Close Menu

Clearing Things Up

Informed consent is no longer serving its purpose, and it's creating more confusion than it is clearing up, says Nature News' Erika Check Hayden. For example, when 23andMe announced it had patented a method to predict the risk of Parkinson's disease, many customers were unhappy, saying they didn't remember consenting to that.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.